...
首页> 外文期刊>Cancer Cell International >LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway
【24h】

LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway

机译:LPAR1通过激活PI3K / AKT信号通路来调节卵巢浆液性囊腺癌中肿瘤内异质性的发展

获取原文
   

获取外文期刊封面封底 >>

       

摘要

To explore the role of lysophosphatidic acid receptor 1 (LPAR1) and its correlation with the PI3K/AKT pathway in the development of intratumoral heterogeneity (ITH) in human ovarian serous cystadenocarcinoma (OSC). Immunohistochemical staining was performed to detect LPAR1 expression in matched primary and recurrent lesions from the same patients. Cell models of ITH were established using the limiting dilution methodology and Transwell invasion/migration assays. LPAR1 expression in the ITH cell models was silenced or upregulated with lentiviral particles, and the biological characteristics were evaluated using various in vitro and in vivo assessments of cell function. The levels of phosphorylated PI3K/AKT (p-PI3K/p-AKT) in LPAR1 knockdown and LPAR1-overexpressing cells were detected. The H-scores for LPAR1 staining in the lymphatic metastatic and recurrent lesions were noticeably higher than in the primary tumor lesions from the same patients (P?=?0.024/0.031). High LPAR1 expression was associated with worse progression-free survival and overall survival (P?=?0.017/0.039). Biological functions in vitro, including invasion, migration, and proliferation, and tumor formation in vivo were decreased in the LPAR1-silenced cells (all P??0.05). These cellular functions were significantly increased in the LPAR1-overexpressing cells in vitro and in vivo (all P??0.05). The levels of p-PI3K and p-AKT were significantly decreased in the LPAR1 knockdown cells and significantly increased in the LPAR1-overexpressing cells (all P??0.05). Higher levels of the LPAR1 protein were associated with a poor prognosis. LPAR1 plays essential roles in the invasion, migration, and proliferation of heterogeneous subsets of OSC cell lines and the development of ITH of OSC, possibly by modulating the activity of the PI3K/AKT signaling pathway.
机译:探讨溶血磷脂酸受体1(LPAR1)的作用及其与PI3K / AKT通路在人卵巢浆液性囊腺癌(OSC)肿瘤内异质性(ITH)发生中的相关性。进行了免疫组织化学染色以检测来自相同患者的匹配的原发和复发病灶中的LPAR1表达。使用有限稀释方法和Transwell入侵/迁移分析建立了ITH细胞模型。用慢病毒颗粒沉默或上调ITH细胞模型中的LPAR1表达,并使用各种细胞功能的体外和体内评估来评估生物学特性。检测LPAR1敲低和LPAR1过表达细胞中磷酸化PI3K / AKT(p-PI3K / p-AKT)的水平。淋巴结转移和复发性病变中LPAR1染色的H值明显高于同一患者的原发性肿瘤病变(P≥0.024/ 0.031)。 LPAR1的高表达与无进展生存期和总生存期较差有关(P≥0.017/ 0.039)。在LPAR1沉默的细胞中,体外的生物学功能,包括侵袭,迁移和增殖,以及体内的肿瘤形成都降低了(所有P <0.05)。在体外和体内,这些细胞功能在过表达LPAR1的细胞中显着增加(所有P <0.05)。在LPAR1敲低的细胞中p-PI3K和p-AKT的水平显着降低,而在过表达LPAR1的细胞中p-PI3K和p-AKT的水平显着升高(所有P <0.05)。 LPAR1蛋白水平较高与预后不良有关。 LPAR1可能通过调节PI3K / AKT信号通路的活性,在OSC细胞异种亚群的侵袭,迁移和增殖以及OSC ITH的形成中起着重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号